FDA Panel Recommends Authorization of Pfizer’s COVID-19 Vaccine for Children 5-11

A person receives a bandage after their first dose of the Pfizer COVID-19 vaccine at a clinic in Los Angeles, Calif., on Aug. 7, 2021. Patrick T. Fallon/AFP via Getty Images

The Food and Drug Administration (FDA) was advised on Tuesday to authorize Pfizer’s COVID-19 vaccine for children between the ages of 5 and 11.

The FDA’s Vaccines and Related Biological Products Advisory Committee made the recommendation.